Is there an association between the use of oral contraception and depressive symptoms in young Australian women?

被引:71
作者
Duke, Janine M.
Sibbritt, David W.
Young, Anne F.
机构
[1] Univ Newcastle, Fac Hlth, Ctr Clin Epidemiol & Biostat, Callaghan, NSW 2308, Australia
[2] Univ Newcastle, Fac Hlth, Res Ctr Gender Hlth & Aging, Callaghan, NSW 2308, Australia
关键词
oral contraception; depression; women's health; longitudinal studies; CORTICOTROPIN-RELEASING-FACTOR; BIRTH-CONTROL; SATISFACTION; SEXUALITY; COHORT; HEALTH; MOOD;
D O I
10.1016/j.contraception.2006.08.002
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Purpose: The purpose of this study was to explore the relationship between oral contraceptive pill (OCP) use and the experience of depressive symptoms among a representative sample of young Australian women. Methods: The study sample comes from the Australian Longitudinal Study on Women's Health. Analysis was confined to women in the youngest cohort who responded to Survey 2, which was conducted in 2000 (n=9688) when they were aged between 22 and 27 years, and to Survey 3, which was conducted in 2003 (n=9081) when they were aged between 25 and 30 years. Results: After adjusting for potential confounders, the odds of a nonuser experiencing depressive symptoms is not significantly different from that of an OCP user [odds ratio=1.05; 95% confidence interval (95% Cl)=0.90-1.21]. Women who used OCP for reasons other than contraception were 1.32 (95% CI= 1.07-1.62) times as likely to be depressed than women who used OCP for contraception. The percentage of women who reported experiencing depressive symptoms declined as the number of years of OCP use increased (p=.009). Conclusions: The results of this study suggest that, after adjusting for confounders, there is no independent effect of OCP use on depressive symptoms in young Australian women. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 26 条
[1]
Andersen E.M., 1994, AM J PREV MED, V10, P77
[2]
The role of corticotropin-releasing factor in depression and anxiety disorders [J].
Arborelius, L ;
Owens, MJ ;
Plotsky, PM ;
Nemeroff, CB .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) :1-12
[3]
Bell S., 2002, PSYCHOL HEALTH MED, V7, P189
[4]
Boey KW, 1999, INT J GERIATR PSYCH, V14, P608, DOI 10.1002/(SICI)1099-1166(199908)14:8<608::AID-GPS991>3.0.CO
[5]
2-Z
[6]
PERSONALITY AS A VULNERABILITY FACTOR TO DEPRESSION [J].
BOYCE, P ;
PARKER, G ;
BARNETT, B ;
COONEY, M ;
SMITH, F .
BRITISH JOURNAL OF PSYCHIATRY, 1991, 159 :106-114
[7]
Brown WJ, 1998, WOMEN HEALTH, V28, P23
[8]
12 YEARS OF CLINICAL-EXPERIENCE WITH AN ORAL-CONTRACEPTIVE CONTAINING 30-MU-G ETHINYLESTRADIOL AND 150-MU-G DESOGESTREL [J].
FOTHERBY, K .
CONTRACEPTION, 1995, 51 (01) :3-12
[9]
Oral contraceptive side effects: Where's the beef? [J].
Goldzieher, JW ;
Zamah, NM .
CONTRACEPTION, 1995, 52 (06) :327-335
[10]
The effects of steroidal contraceptives on the well-being and sexuality of women: A double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods [J].
Graham, CA ;
Ramos, R ;
Bancroft, J ;
Maglaya, C ;
Farley, TMM .
CONTRACEPTION, 1995, 52 (06) :363-369